41 reports

Moreover, according to the Stanford Children' s Health data published in 2018, the United States has nearly ##. ## million children and teen (## years and below) are suffering from injuries.

  • Musculoskeletal Disorder
  • World
  • Forecast
  • Market Size
  • Zimmer Biomet Holdings, Inc.

For instance, Stanford Children' s Health suggested that among ## million children involved in sports in the United States, around ##. ## million witness sports injuries every year.

  • Musculoskeletal Disorder
  • Arthrex, Inc.
  • DePuy Orthopaedics, Inc.
  • EmCyte Corporation
  • Synthes, Inc.

Prior to joining GlobalData, Suneedh worked for the Public Health Foundation of India (PHFI) in various research projects including tobacco control, maternal and child health, and HIV prevention.

  • Arthritis
  • Musculoskeletal Disorder
  • United States
  • Forecast

A notable example is China' s one-child policy that was instituted in 1981.

  • Musculoskeletal Disorder
  • North America
  • United States
  • World
  • Market Size
  • REGION

Moreover, China' s one-child policy has drastically reduced the working-age population and increased the geriatric population in the country.

  • Musculoskeletal Disorder
  • North America
  • United States
  • Market Size
  • Pfizer Inc.

National Institutes of Health.

  • Autoimmune Disease
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Therapy
  • United States
  • DRUGS TO CHELATE IRON FOR BONE DEGENERATION, POSTMENOPAUSAL OSTEOPOROSIS AND THALASSEMIA - DRUG PROFILE
  • DRUGS TO CHELATE IRON FOR BONE DEGENERATION, POSTMENOPAUSAL OSTEOPOROSIS AND THALASSEMIA - DRUG PROFILE

RADIUS HEALTH AND NORDIC ENTERED INTO A CLINICAL TRIAL SERVICES AGREEMENT, A WORK STATEMENT NB-##, OR THE WORK STATEMENT NB-##, UNDER SUCH CLINICAL TRIAL SERVICES AGREEMENT AND A RELATED STOCK ISSUANCE AGREEMENT.

  • Biosimilar
  • Chronic Disease
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Amgen Inc.

The prominent features of this report are - ##.

  • Clinical Trial
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Therapy
  • World
  • Clinical Trial profile. 233 Trial Title
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Pharmaceutical
  • World
  • REFERENCES

The European Spanish version of the childhood health assessment questionnaire (CHAQ) and the child health questionnaire (CHQ).

  • Musculoskeletal Disorder
  • Pathology

The molecules developed by Companies in Phase III, Phase II and Phase I stages are ##, ## and ## respectively.

  • Autoimmune Disease
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Therapy
  • United States
  • Target

(Inactive) ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Medtronic Plc Ionis Pharmaceuticals Inc Genethon SA Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2018 2018 trials ar

  • Clinical Trial
  • Drug Development
  • Musculoskeletal Disorder
  • World
  • Product Initiative

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Merck & Co Inc ## ## ## ## ## ## ## ## Amgen Inc ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## ## Radius Health Inc ## ## ## ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## ##

  • Clinical Trial
  • Endocrine Disease
  • Musculoskeletal Disorder
  • Therapy
  • Eli Lilly & Co.

National Institutes of Health.

  • Musculoskeletal Disorder
  • United States
  • World
  • Product Initiative
  • Clementia Pharmaceuticals Inc.

Bhd. ## May 2011 ## ## An Open, Randomized, Cross-over Study of Comparative Pharmacokinetics and Bioequivalence of Drugs Ibuprofen Rectal Suppositories for Children (Ojsc Biosynthesis, Russia) and Nurofen Rectal Suppositories for Children (Recitt Benkizer Helsker In

  • Chronic Disease
  • Musculoskeletal Disorder
  • Pharmaceutical
  • World
  • Product Initiative
  • DRUGS TO CHELATE IRON FOR BONE DEGENERATION, POSTMENOPAUSAL OSTEOPOROSIS AND THALASSEMIA - DRUG PROFILE

RADIUS HEALTH AND NORDIC ENTERED INTO A CLINICAL TRIAL SERVICES AGREEMENT, A WORK STATEMENT NB-##, OR THE WORK STATEMENT NB-##, UNDER SUCH CLINICAL TRIAL SERVICES AGREEMENT AND A RELATED STOCK ISSUANCE AGREEMENT.

  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • United States
  • Product Initiative
  • Amgen Inc.

UCSF serves in the areas of cancer, children' s health, diabetes, heart and vascularimmunology and infectious diseasesstem cells, transplant services, neurology and neurosurgerytranslational medicine and women' s health.

  • Clinical Trial
  • Drug Development
  • Musculoskeletal Disorder
  • United States
  • Grifols, S.A.
  • 5. All the trials included are unique trials.

Ltd., India) in Comparison with the Drug Nurofen for Children, Suspension for Oral Administration, ## Mg / ## Ml (Rekitt Benkizer Helsker International Ltd., Great Britain) and Children' s Panadol Suspension for Oral Administration, ## Mg / ## Ml (Pharmacler, France)

  • Musculoskeletal Disorder
  • OTC
  • Pharmaceutical
  • World
  • Product Initiative

Hoffmann-La Roche Ltd GlaxoSmithKline Plc ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Galapagos NV ## ## ## ## ## ## UCB SA ## ## ## ## ## ## Pamplona Capital Management LLP ## ## ## ## ## ## Kadmon Holdings Inc ## ##

  • Clinical Trial
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • World
  • Novartis AG
  • Official Title
  • Clinical Trial profile. 237 Trial Title

Hoffmann-La Roche Ltd Merck & Co Inc ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Amgen Inc ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## GlaxoSmithKline Plc Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## ##

  • Clinical Trial
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Therapy
  • World

Hershey Medical Center National Institutes of Health ## Aug 2007 ## Mar 2011 ## Apr 2011 ## ## ## ## ## Sildenafil Citrate in the Treatment of Primary Dysmenorrhea Viagra in the Treatment of Primary Dysmenorrhea GDCT## NCT##, ## Women' s Health Primary Dysm

  • Anti Rheumatic
  • Musculoskeletal Disorder
  • Pharmaceutical
  • World
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS

## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## France Source: GlobalData' s Pharma Intelligence Center Clinical

  • Musculoskeletal Disorder
  • Pharmaceutical
  • World
  • Product Initiative
  • F. Hoffmann-La Roche Ltd.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

RHEUMATIC DISORDERS THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* RHEUMATIC DISORDERS THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* Country Name Phase IV Phase III Phase II/ III Phase II Phase I/ II Phase I Phase ## Total United States ## ## ## ## ## ##

  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Pain Relief
  • World
  • Product Initiative

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Musculoskeletal Disorder
  • Opioid
  • World
  • Product Initiative
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Medical Biotechnology
  • Musculoskeletal Disorder
  • Targeted Therapy
  • World
  • DRUGS TO CHELATE IRON FOR BONE DEGENERATION, POSTMENOPAUSAL OSTEOPOROSIS AND THALASSEMIA - DRUG PROFILE

REGISTERED A PHASE III STUDY TO EVALUATE EFFICACY AND SAFETY OF DENOSUMAB IN CHILDREN WITH OSTEOGENESIS IMPERFECTA.

  • Musculoskeletal Disorder
  • Oncology
  • Pharmaceutical
  • Company
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS

## ## Canada ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## France ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## Japan Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database

  • Clinical Trial
  • Musculoskeletal Disorder
  • Pain Relief
  • World
  • Product Initiative

BRUCE VALLANCE AT THE CHILD & FAMILY RESEARCH INSTITUTE AT BC CHILDREN S HOSPITAL AND THE UNIVERSITY OF BRITISH COLUMBIA.

  • Arthritis
  • Musculoskeletal Disorder
  • Pathology
  • Therapy
  • AbbVie Inc.

Therapeutic Trial of Growth Hormone Severe Decrease of Growth Velocity in Children with Anorexia Nervosa.

  • Clinical Trial
  • Endocrine Disease
  • Musculoskeletal Disorder
  • World
  • Amgen Inc.
  • 3. GDCT ID IS THE UNIQUE ID OF GLOBALDATA'S PHARMA INTELLIGENCE CENTER CLINICAL TRIAL DATABASE

In the study, ## patients were randomized ##:##:## to receive placebo, baricitinib ## mg or baricitinib ## mg.

  • Clinical Trial
  • Medical Biotechnology
  • Musculoskeletal Disorder
  • World
  • GlaxoSmithKline plc